Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Edward T. Anderson currently holds 97,948 shares of Lyra Therapeutics, Inc. (LYRA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Edward T. Anderson has been a net buyer of LYRA stock. They have purchased $23.2M and sold $408.6K worth of shares.
Edward T. Anderson's most recent insider trade was on Sep 24, 2025, when they sold 1,987,084 shares at $0.00 per share.
Edward T. Anderson serves as Executive at Lyra Therapeutics, Inc. (LYRA). They have executed 58 insider transactions totaling $23.6M over their tenure at the company.
Edward T. Anderson holds the position of Executive at Lyra Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
Edward T. Anderson has shown a buying trading pattern, with $23.2M in total purchases and $408.6K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Edward T. Anderson was on Apr 12, 2022, when they purchased $4.5M worth of LYRA shares. This transaction involved 1,076,851 shares at $4.22 per share.
Edward T. Anderson currently owns 97,948 shares of Lyra Therapeutics, Inc. (LYRA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Edward T. Anderson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Edward T. Anderson has 58 Form 4 filings on record as an insider at Lyra Therapeutics, Inc..
Set alerts for Edward T. Anderson and 40,000+ other insiders.